210 related articles for article (PubMed ID: 25787058)
1. A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.
Giovannoni G; de Jong B; Derfuss T; Izquierdo G; Mazibrada G; Molyneux P; Nicholas R; Overell J; Ziemssen T; Juliusson G
Mult Scler Relat Disord; 2015 Jan; 4(1):83-4. PubMed ID: 25787058
[No Abstract] [Full Text] [Related]
2. Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?
Avasarala J; Jain S; Urrea-Mendoza E
J Clin Pharmacol; 2017 Nov; 57(11):1415-1418. PubMed ID: 28543950
[No Abstract] [Full Text] [Related]
3. Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Artemiadis AK; Nikolaou G; Kolokythopoulos D; Tegos N; Terentiou A; Triantafyllou N; Papanastasiou I
Mult Scler; 2015 May; 21(6):795-6. PubMed ID: 25432949
[No Abstract] [Full Text] [Related]
4. [Fingolimod].
Hashi Y; Kondo T
Nihon Rinsho; 2015 Sep; 73 Suppl 7():205-11. PubMed ID: 26480701
[No Abstract] [Full Text] [Related]
5. Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
Fragoso YD; Adoni T; Gomes S; Goncalves MV; Matta AP; Mendes MF; Siquineli F
Headache; 2015 Apr; 55(4):578-9. PubMed ID: 25754576
[No Abstract] [Full Text] [Related]
6. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis.
Gündüz T; Kürtüncü M; Eraksoy M
Mult Scler Relat Disord; 2017 Jan; 11():1-3. PubMed ID: 28104247
[No Abstract] [Full Text] [Related]
7. Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Thoo S; Cugati S; Lee A; Chen C
Mult Scler; 2015 Feb; 21(2):249-51. PubMed ID: 24696055
[TBL] [Abstract][Full Text] [Related]
8. Aggressive cutaneous leishmaniasis in a patient with multiple sclerosis treated with fingolimod.
Hernández Clares R; Sánchez Pedreño P; García Vazquez E; Carreón Guarnizo E; Meca Lallana JE
Neurologia (Engl Ed); 2018 Jun; 33(5):348-349. PubMed ID: 28535923
[No Abstract] [Full Text] [Related]
9. Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Ueda N; Saida K
BMC Ophthalmol; 2015 Oct; 15():135. PubMed ID: 26481728
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster: a potential risk associated with fingolimod treatment.
Mayor Ibarguren A; Gómez Fernández C; Tallón Barranco A; Fernández Fournier M; González Ramos J; Romero Gómez MP; Herranz Pinto P
Int J Dermatol; 2015 Sep; 54(9):e373-5. PubMed ID: 26173466
[No Abstract] [Full Text] [Related]
11. Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Forrestel AK; Modi BG; Longworth S; Wilck MB; Micheletti RG
JAMA Neurol; 2016 Mar; 73(3):355-6. PubMed ID: 26751160
[No Abstract] [Full Text] [Related]
12. Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia.
Caliendo D; Grassia MC; Carotenuto A; Petracca M; Lanzillo R; Brescia Morra V; Moccia M
Mult Scler Relat Disord; 2024 Jan; 81():105135. PubMed ID: 38006850
[TBL] [Abstract][Full Text] [Related]
13. Polydermatomal perineal and gluteal herpes zoster infection in a patient on fingolimod treatment.
Kawiorski MM; Viedma-Guiard E; Costa-Frossard L; Corral I
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):138-9. PubMed ID: 24958672
[No Abstract] [Full Text] [Related]
14. Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod.
Manouchehri N; Mirmosayyeb O; Badihian S; Shaygannejad V
Mult Scler Relat Disord; 2018 Jan; 19():121-123. PubMed ID: 29195114
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte recovery after fingolimod discontinuation in patients with MS.
Nagy S; Kuhle J; Derfuss T
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32801166
[TBL] [Abstract][Full Text] [Related]
16. A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Stitt DW; Boes CJ; Flanagan EP; Howard MT; Colgan JP
Mult Scler Relat Disord; 2018 Jan; 19():115-117. PubMed ID: 29190574
[TBL] [Abstract][Full Text] [Related]
17. Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Flores J; Rito Y; Torres G; Jung H; Treviño-Frenk I; Corona T
J Neurol Sci; 2015 Jan; 348(1-2):272-3. PubMed ID: 25491264
[No Abstract] [Full Text] [Related]
18. Fingolimod (Gilenya) and melanoma.
Robinson CL; Guo M
BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28003234
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmia in a male MS patient on fingolimod.
van Pesch V; Marchandise S; El Sankari S; Sindic C
Acta Neurol Belg; 2015 Mar; 115(1):77-9. PubMed ID: 24710722
[No Abstract] [Full Text] [Related]
20. Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod.
Członkowska A; Smoliński Ł; Litwin T
Neurol Neurochir Pol; 2017; 51(2):156-162. PubMed ID: 28209440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]